Current understanding of fungal microflora in inflammatory bowel disease pathogenesis

David Underhill1, Jonathan Braun

  • 1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.

Inflammatory Bowel Diseases
|February 21, 2008
PubMed

Insights

Inflammatory bowel diseases (IBD) are a growing public health concern. This review explores the role of enteric fungi, beyond bacteria, in IBD susceptibility and disease development.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Inflammatory bowel diseases (IBD) represent a significant and increasing global health burden.
  • Current research primarily investigates the role of gut bacteria in IBD pathogenesis.
  • The potential contribution of the gut mycobiome to IBD remains underexplored.

Purpose of the Study:

  • To review the current understanding of enteric fungi in the context of inflammatory bowel diseases.
  • To explore the mechanisms by which fungal dysbiosis may influence IBD susceptibility.
  • To highlight the importance of considering fungi in IBD research.

Main Methods:

  • Comprehensive literature review of studies on enteric fungi and IBD.
  • Analysis of proposed mechanisms linking fungal dysregulation to bowel inflammation.
  • Synthesis of existing knowledge on the gut mycobiome and IBD.

Main Results:

  • Enteric fungi are a component of the gut microbiome and their composition can be altered in IBD patients.
  • Fungal dysbiosis may contribute to IBD through various mechanisms, including immune system modulation and barrier function disruption.
  • Specific fungal species and their metabolites have been implicated in promoting or exacerbating inflammation.

Conclusions:

  • Enteric fungi, in addition to bacteria, are likely involved in the pathogenesis of inflammatory bowel diseases.
  • Fungal dysregulation represents a potential therapeutic target for IBD.
  • Further research is warranted to elucidate the precise roles of specific fungi in IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...